Trial Profile
Drug Use Investigation for ALLERMIST.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2023
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 23 Jun 2011 New trial record